Validations: AI/ML Model Validation in GxP Analytics
Training & Competency for AI Teams: A Step-by-Step Guide Introduction to AI/ML Model Validation in GxP Analytics The integration of Artificial Intelligence (AI) and Machine Learning (ML) into Good Practice (GxP) analytics has transformed pharmaceutical processes, enabling innovative solutions that enhance efficiency and accuracy. However, the deployment of AI/ML models within regulated environments necessitates a rigorous training and competency framework…
API Governance for Model Serving API Governance for Model Serving: A Comprehensive Guide In the evolving landscape of pharmaceutical innovation, artificial intelligence and machine learning (AI/ML) are emerging as critical tools for enhancing GxP (Good Practice) analytics. However, the deployment of these technologies requires stringent governance frameworks to ensure compliance with regulatory standards. This article serves as a step-by-step tutorial…
Approval Workflows: Dev → Test → Prod Approval Workflows: Dev → Test → Prod Artificial Intelligence (AI) and Machine Learning (ML) are increasingly becoming pivotal in the pharmaceutical sector, especially within GxP (Good Practice) analytics. However, deploying AI-driven solutions necessitates a stringent validation process to comply with regulatory standards set by authorities like the US FDA, EMA, MHRA, and relevant…
Segregation of Duties in MLOps The incorporation of Machine Learning (ML) within Good Practice (GxP) regulated environments has highlighted the importance of segregation of duties (SoD) to manage risks effectively. Establishing clear guidelines regarding AI/ML model validation, including considerations of intended use risk, data readiness curation, bias and fairness testing, and model verification and validation, is essential for compliance with…
Key Management & Secrets in Model Ops Key Management & Secrets in Model Ops: A Comprehensive Guide for Pharma Professionals Introduction to AI/ML Model Validation in GxP Analytics As the integration of artificial intelligence (AI) and machine learning (ML) technologies into pharmaceutical operations increases, the need for stringent model validation processes becomes clear. This guide aims to navigate key management…
Vulnerability Scans & Pen Tests for AI Pipelines Vulnerability Scans & Pen Tests for AI Pipelines Introduction to AI/ML Model Validation in GxP Analytics Artificial Intelligence (AI) and Machine Learning (ML) are transforming the landscape of pharmaceutical development, particularly in Good Practice (GxP) analytics. As regulatory bodies like the FDA, European Medicines Agency (EMA), and Medicines and Healthcare products Regulatory…
Security-by-Design for Models: Threat Models & Mitigations In the rapidly evolving landscape of AI and machine learning (ML) within the pharmaceutical sector, the integration of robust validation frameworks is critical for ensuring compliance with regulatory standards such as 21 CFR Part 11 and EU Annex 11. This tutorial provides a comprehensive overview and step-by-step guidance on implementing Security-by-Design principles to…
Access Control for Features, Models, and Outputs Access Control for Features, Models, and Outputs in AI/ML Model Validation The rapid integration of artificial intelligence (AI) and machine learning (ML) in the pharmaceutical industry has transformed the landscape of drug discovery, development, and clinical applications. With the potential for significant implications on patient safety and product efficacy, regulatory agencies such as…
Cybersecurity Hooks: NIST/CIS Controls for AI Cybersecurity Hooks: NIST/CIS Controls for AI Introduction to AI/ML in GxP Analytics As artificial intelligence (AI) and machine learning (ML) technologies permeate pharmaceutical and biopharmaceutical landscapes, the necessity for rigorous model validation procedures becomes paramount. Regulatory bodies such as the FDA, EMA, and MHRA have set forth guidelines that necessitate clear documentation and verification…
Third-Party/Vendor Risk for AI Components Third-Party/Vendor Risk for AI Components The integration of Artificial Intelligence (AI) and Machine Learning (ML) in Good Automated Manufacturing Practice (GxP) analytics plays a pivotal role in the pharmaceutical sector, enhancing productivity and innovation. However, the incorporation of third-party AI components introduces inherent risks that must be managed effectively. This guide outlines a step-by-step approach…